Detalhe da pesquisa
1.
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.
Clin Cancer Res
; 30(1): 82-93, 2024 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882661
2.
Phenotypic and molecular states of IDH1 mutation-induced CD24-positive glioma stem-like cells.
Neoplasia
; 28: 100790, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398668